Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
BT
BioLib Technologies ApS
aktivCVR 40705341AnpartsselskabKultorvet 11, 3, 1175 København KAnden udgivelse af software
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 05 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Not available from the published filing—
Not available from the published filing
Operating profit
DKK 1.9m
Latest period
Source details
Source: dk-regnskabsdata-live-40705341-1793900030259
Document: dk-regnskabsdata-40705341-AZ7HZoQaJsD7XaxeVdAZ-1
XBRL: d:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c11
Unit: u3
Net result
DKK 1.4m
Latest period
Source details
Source: dk-regnskabsdata-live-40705341-1793900030259
Document: dk-regnskabsdata-40705341-AZ7HZoQaJsD7XaxeVdAZ-1
XBRL: d:ProfitLoss
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c11
Unit: u3
Equity
DKK 4.7m
Equity ratio: 81.8%
Source details
Source: dk-regnskabsdata-live-40705341-1793900030259
Document: dk-regnskabsdata-40705341-AZ7HZoQaJsD7XaxeVdAZ-1
XBRL: d:Equity
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c49
Unit: u3
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2022 | — | DKK 114.8k |
| 2023 | — | DKK 1.2m |
| 2024 | — | DKK 1.6m |
| 2025 | — | DKK 1.4m |